Skip to main content
. 2019 Sep 10;27(11):1930–1938. doi: 10.1016/j.ymthe.2019.08.020

Table 2.

Patient Serologic Responses to a Single Dose of Intravenous Seprehvir

Patient No. WBC ANC ALC HSV-1 PCR Blood HSV-1 Seroconversion (IgG/IgM)
Day S S S S 0a 1 4 7 14 21 28 S 28
HSV01 9.1 5,600 1,638 + + + NA NA NA
HSV02 6.2 4,030 1,612 + +IgM
HSV03 13.5 9,585 1,620 ND ND ND ND ND
HSV04 4.2 2,772 966 + +IgM
HSV05 5.4 3,078 864 ND ND ND ND
HSV06 5.8 5,046 348 + + + + ND
HSV07 3.5 2,100 910 +IgM
HSV08 8.8 5,280 2,376 + + + + + + +IgM, +IgG
HSV09 4.6 3,634 414 +IgM
HSV09-II 4.7 3,384 705 +b +IgM +IgM, +IgG

ALC, absolute lymphocyte count; ANC, absolute neutrophil count; NA, not applicable (patient deceased); ND, not done; S, screening; WBC, white blood cell count.

a

Measured at 3, 6, and 18 h after virus injection.

b

Measured only at 3 h after virus injection.